Endometrial carcinoma in previously ovariectomized patients

Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter.

CPT: pharmacometrics & systems pharmacology·2016

Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2016

Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of Rosuvastatin.

CPT: pharmacometrics & systems pharmacology·2014

A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine.

Clinical pharmacokinetics·2013

Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption.

Biopharmaceutics & drug disposition·2012

Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.

Current drug metabolism·2010

Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study.

Gynecologic oncology·2026

Factors associated with non-completion of gynecological cancer clinical trials.

Gynecologic oncology·2026

Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes.

Gynecologic oncology·2026

Feasibility, adherence, and patient experiences in a pilot randomized trial of home-based cognitive training intervention for gynecologic cancer-related cognitive impairment.

Gynecologic oncology·2026

Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.

Gynecologic oncology·2026

The feasibility of a medically supervised preoperative weight loss program in patients with obesity and atypical hyperplasia, or low-grade endometrial carcinoma.

Gynecologic oncology·2026

An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy.

Inflammopharmacology·2026

BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity.

Therapeutic innovation & regulatory science·2026

OCT4 modulates Pomc gene transcription by interfering with specific corticotroph transcription factors.

Journal of endocrinological investigation·2026

Inherently Therapeutic Plasmalogen-Based Nanoparticle Platform to Kill Ovarian Cancer Cells via Synergistic Ferroptosis Induction.

ACS biomaterials science & engineering·2026

Neurocognitive functioning of patients treated for pediatric craniopharyngioma and predictors of outcomes.

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence·2026

GLUT-Mediated Uptake of Glyco-Trojan Horse Enables Targeted PDT for Breast Cancer.

Biomacromolecules·2026

Related Experiment Videos

Endometrial carcinoma in previously ovariectomized patients

Related Concept Videos

Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter.

Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.

Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of Rosuvastatin.

A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine.

Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption.

Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.

Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study.

Factors associated with non-completion of gynecological cancer clinical trials.

Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes.

Feasibility, adherence, and patient experiences in a pilot randomized trial of home-based cognitive training intervention for gynecologic cancer-related cognitive impairment.

Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.

The feasibility of a medically supervised preoperative weight loss program in patients with obesity and atypical hyperplasia, or low-grade endometrial carcinoma.

An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy.

BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity.

OCT4 modulates Pomc gene transcription by interfering with specific corticotroph transcription factors.

Inherently Therapeutic Plasmalogen-Based Nanoparticle Platform to Kill Ovarian Cancer Cells via Synergistic Ferroptosis Induction.

Neurocognitive functioning of patients treated for pediatric craniopharyngioma and predictors of outcomes.

GLUT-Mediated Uptake of Glyco-Trojan Horse Enables Targeted PDT for Breast Cancer.

Related Experiment Videos

Endometrial carcinoma in previously ovariectomized patients

Related Concept Videos

Related Articles